<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6457314</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">31001097</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6457314</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fnhum.2019.00107</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Demographics, clinical data, mood and cognitive performance among Ulcerative colitis (UC) and healthy control (HC).</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p>Demographics, clinical data, mood and cognitive performance among Ulcerative colitis (UC) and healthy control (HC).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1">Characteristic</th><th align="center" rowspan="1" colspan="1">UC patients (<italic>n</italic> = 41)</th><th align="center" rowspan="1" colspan="1">Heathy controls (<italic>n</italic> = 42)</th><th align="center" rowspan="1" colspan="1"><italic>p</italic> Value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">37.10 ± 9.45</td><td align="center" rowspan="1" colspan="1">36.86 ± 9.02</td><td align="center" rowspan="1" colspan="1">0.766<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Gender (male/female)</td><td align="center" rowspan="1" colspan="1">25/16</td><td align="center" rowspan="1" colspan="1">25/17</td><td align="center" rowspan="1" colspan="1">0.943<sup>b</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Education (years)</td><td align="center" rowspan="1" colspan="1">11.85 ± 3.62</td><td align="center" rowspan="1" colspan="1">12.48 ± 3.20</td><td align="center" rowspan="1" colspan="1">0.383<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Disease duration (months)</td><td align="center" rowspan="1" colspan="1">39.58 ± 39.28</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Montreal classification</td><td align="center" rowspan="1" colspan="1">E1:E2:E3 = 11:12:18</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mayo</td><td align="center" rowspan="1" colspan="1">4.66 ± 1.53</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CRP</td><td align="center" rowspan="1" colspan="1">8.58 ± 7.91</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ESR</td><td align="center" rowspan="1" colspan="1">12.67 ± 10.02</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">PLT</td><td align="center" rowspan="1" colspan="1">289.00 ± 94.87</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IBDQ</td><td align="center" rowspan="1" colspan="1">152.07 ± 32.28</td><td align="center" rowspan="1" colspan="1">193.04 ± 17.32</td><td align="center" rowspan="1" colspan="1">&lt;0.001<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">PSQI</td><td align="center" rowspan="1" colspan="1">8.48 ± 4.53</td><td align="center" rowspan="1" colspan="1">3.40 ± 2.25</td><td align="center" rowspan="1" colspan="1">&lt;0.001<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">VAS</td><td align="center" rowspan="1" colspan="1">1 (0–7)</td><td align="center" rowspan="1" colspan="1">0 (0–2)</td><td align="center" rowspan="1" colspan="1">&lt;0.001<sup>c</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">PSS</td><td align="center" rowspan="1" colspan="1">17.95 ± 9.27</td><td align="center" rowspan="1" colspan="1">14.88 ± 7.02</td><td align="center" rowspan="1" colspan="1">0.013<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Emotion</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HADS-A</td><td align="center" rowspan="1" colspan="1">6.29 ± 3.43</td><td align="center" rowspan="1" colspan="1">4.45 ± 2.43</td><td align="center" rowspan="1" colspan="1">0.016<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">HADS-D</td><td align="center" rowspan="1" colspan="1">5.78 ± 3.97</td><td align="center" rowspan="1" colspan="1">4.09 ± 2.27</td><td align="center" rowspan="1" colspan="1">&lt;0.001<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">SAS</td><td align="center" rowspan="1" colspan="1">43.78 ± 11.17</td><td align="center" rowspan="1" colspan="1">32.05 ± 5.64</td><td align="center" rowspan="1" colspan="1">&lt;0.001<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">SDS</td><td align="center" rowspan="1" colspan="1">39.32 ± 10.19</td><td align="center" rowspan="1" colspan="1">33.54 ± 7.23</td><td align="center" rowspan="1" colspan="1">0.002<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Attention</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ANT alerting effect (ms)</td><td align="center" rowspan="1" colspan="1">45.63 ± 26.04</td><td align="center" rowspan="1" colspan="1">36.50 ± 15.75</td><td align="center" rowspan="1" colspan="1">0.048<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">ANT orienting effect (ms)</td><td align="center" rowspan="1" colspan="1">25.51 ± 34.05</td><td align="center" rowspan="1" colspan="1">29.76 ± 33.62</td><td align="center" rowspan="1" colspan="1">0.806<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">ANT executive effect (ms)</td><td align="center" rowspan="1" colspan="1">115.07 ± 43.36</td><td align="center" rowspan="1" colspan="1">92.98 ± 34.58</td><td align="center" rowspan="1" colspan="1">0.044<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Executive function</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ACC of stroop (%)</td><td align="center" rowspan="1" colspan="1">87.0 (69.2–95.0)</td><td align="center" rowspan="1" colspan="1">95.0 (88.0–97.0)</td><td align="center" rowspan="1" colspan="1">&lt;0.001<sup>c</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Stroop RT (ms)</td><td align="center" rowspan="1" colspan="1">791.52 ± 119.92</td><td align="center" rowspan="1" colspan="1">663.49 ± 81.72</td><td align="center" rowspan="1" colspan="1">0.022<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Work memory</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ACC of two-back (%)</td><td align="center" rowspan="1" colspan="1">73.0 (65.5–82.0)</td><td align="center" rowspan="1" colspan="1">87.0 (78.0–91.25)</td><td align="center" rowspan="1" colspan="1">&lt;0.001<sup>c</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">Two-back RT (ms)</td><td align="center" rowspan="1" colspan="1">722.28 ± 137.86</td><td align="center" rowspan="1" colspan="1">638.30 ± 97.54</td><td align="center" rowspan="1" colspan="1">0.031<sup>a</sup></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Medication</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mesalazine SR granules (3 g, po, qd)</td><td align="center" rowspan="1" colspan="1">E2 + E3 (30) 30 patients</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mesalazine suppository (1 g, rectally, qn)</td><td align="center" rowspan="1" colspan="1">E1 (11) 11 patients</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p><italic>Abbreviations: CPR, C-reactive protein; ESR, erythrocyte sedimentation rate; PLT, platelet count; IBDQ, Inflammatory Bowel Disease Questionnaire; HADS, Hospital Anxiety and Depression Scale; SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale; PSQI, Pittsburgh Sleep Quality Index; VAS, Visual Analogue Scale; ANT, Attention Network Task; ACC, accuracy rating; RT, reaction time. <sup>a</sup>Two-sample independent <italic>t</italic>-test. <sup>b</sup>Chi-square test. <sup><italic>c</italic></sup>Mann-Whitney rank test</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographics, clinical data, mood and cognitive performance among Ulcerative colitis (UC) and healthy control (HC).</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="center">Characteristic</th><th align="center">UC patients (n = 41)</th><th align="center">Heathy controls (n = 42)</th><th align="center">p Value</th></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="center">37.10 ± 9.45</td><td align="center">36.86 ± 9.02</td><td align="center">0.766a</td></tr><tr><td align="left">Gender (male/female)</td><td align="center">25/16</td><td align="center">25/17</td><td align="center">0.943b</td></tr><tr><td align="left">Education (years)</td><td align="center">11.85 ± 3.62</td><td align="center">12.48 ± 3.20</td><td align="center">0.383a</td></tr><tr><td align="left">Disease duration (months)</td><td align="center">39.58 ± 39.28</td><td/><td/></tr><tr><td align="left">Montreal classification</td><td align="center">E1:E2:E3 = 11:12:18</td><td/><td/></tr><tr><td align="left">Mayo</td><td align="center">4.66 ± 1.53</td><td/><td/></tr><tr><td align="left">CRP</td><td align="center">8.58 ± 7.91</td><td/><td/></tr><tr><td align="left">ESR</td><td align="center">12.67 ± 10.02</td><td/><td/></tr><tr><td align="left">PLT</td><td align="center">289.00 ± 94.87</td><td/><td/></tr><tr><td align="left">IBDQ</td><td align="center">152.07 ± 32.28</td><td align="center">193.04 ± 17.32</td><td align="center">&lt;0.001a</td></tr><tr><td align="left">PSQI</td><td align="center">8.48 ± 4.53</td><td align="center">3.40 ± 2.25</td><td align="center">&lt;0.001a</td></tr><tr><td align="left">VAS</td><td align="center">1 (0–7)</td><td align="center">0 (0–2)</td><td align="center">&lt;0.001c</td></tr><tr><td align="left">PSS</td><td align="center">17.95 ± 9.27</td><td align="center">14.88 ± 7.02</td><td align="center">0.013a</td></tr><tr><td align="left">Emotion</td><td/><td/><td/></tr><tr><td align="left">HADS-A</td><td align="center">6.29 ± 3.43</td><td align="center">4.45 ± 2.43</td><td align="center">0.016a</td></tr><tr><td align="left">HADS-D</td><td align="center">5.78 ± 3.97</td><td align="center">4.09 ± 2.27</td><td align="center">&lt;0.001a</td></tr><tr><td align="left">SAS</td><td align="center">43.78 ± 11.17</td><td align="center">32.05 ± 5.64</td><td align="center">&lt;0.001a</td></tr><tr><td align="left">SDS</td><td align="center">39.32 ± 10.19</td><td align="center">33.54 ± 7.23</td><td align="center">0.002a</td></tr><tr><td align="left">Attention</td><td/><td/><td/></tr><tr><td align="left">ANT alerting effect (ms)</td><td align="center">45.63 ± 26.04</td><td align="center">36.50 ± 15.75</td><td align="center">0.048a</td></tr><tr><td align="left">ANT orienting effect (ms)</td><td align="center">25.51 ± 34.05</td><td align="center">29.76 ± 33.62</td><td align="center">0.806a</td></tr><tr><td align="left">ANT executive effect (ms)</td><td align="center">115.07 ± 43.36</td><td align="center">92.98 ± 34.58</td><td align="center">0.044a</td></tr><tr><td align="left">Executive function</td><td/><td/><td/></tr><tr><td align="left">ACC of stroop (%)</td><td align="center">87.0 (69.2–95.0)</td><td align="center">95.0 (88.0–97.0)</td><td align="center">&lt;0.001c</td></tr><tr><td align="left">Stroop RT (ms)</td><td align="center">791.52 ± 119.92</td><td align="center">663.49 ± 81.72</td><td align="center">0.022a</td></tr><tr><td align="left">Work memory</td><td/><td/><td/></tr><tr><td align="left">ACC of two-back (%)</td><td align="center">73.0 (65.5–82.0)</td><td align="center">87.0 (78.0–91.25)</td><td align="center">&lt;0.001c</td></tr><tr><td align="left">Two-back RT (ms)</td><td align="center">722.28 ± 137.86</td><td align="center">638.30 ± 97.54</td><td align="center">0.031a</td></tr><tr><td align="left">Medication</td><td/><td/><td/></tr><tr><td align="left">Mesalazine SR granules (3 g, po, qd)</td><td align="center">E2 + E3 (30) 30 patients</td><td/><td/></tr><tr><td align="left">Mesalazine suppository (1 g, rectally, qn)</td><td align="center">E1 (11) 11 patients</td><td/><td/></tr></tbody></table></div>Abbreviations: CPR, C-reactive protein; ESR, erythrocyte sedimentation rate; PLT, platelet count; IBDQ, Inflammatory Bowel Disease Questionnaire; HADS, Hospital Anxiety and Depression Scale; SAS, Self-Rating Anxiety Scale; SDS, Self-Rating Depression Scale; PSQI, Pittsburgh Sleep Quality Index; VAS, Visual Analogue Scale; ANT, Attention Network Task; ACC, accuracy rating; RT, reaction time. aTwo-sample independent t-test. bChi-square test. cMann-Whitney rank test.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2</table-label><table-caption>ALFF alterations between the UC and HC groups.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2</label><caption><p>ALFF alterations between the UC and HC groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th align="center" colspan="3" rowspan="1">MNI peak point coordinates</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1">Brain region</th><th align="center" rowspan="1" colspan="1">BA</th><th align="center" rowspan="1" colspan="1">Hem</th><th align="center" colspan="1" rowspan="1"><italic>X</italic></th><th align="center" colspan="1" rowspan="1"><italic>Y</italic></th><th align="center" colspan="1" rowspan="1"><italic>Z</italic></th><th align="center" colspan="1" rowspan="1"><italic>t</italic>-Value</th><th align="center" rowspan="1" colspan="1">Voxels</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">HIPP/ParaHIPP</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">L&amp;R</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">−3</td><td align="center" rowspan="1" colspan="1">−30</td><td align="center" rowspan="1" colspan="1">−4.9212</td><td align="center" rowspan="1" colspan="1">253</td></tr><tr><td align="left" rowspan="1" colspan="1">PCC</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">L</td><td align="center" rowspan="1" colspan="1">−15</td><td align="center" rowspan="1" colspan="1">−66</td><td align="center" rowspan="1" colspan="1">−12</td><td align="center" rowspan="1" colspan="1">4.3442</td><td align="center" rowspan="1" colspan="1">58</td></tr><tr><td align="left" rowspan="1" colspan="1">MFG</td><td align="center" rowspan="1" colspan="1">9/10</td><td align="center" rowspan="1" colspan="1">L</td><td align="center" rowspan="1" colspan="1">−18</td><td align="center" rowspan="1" colspan="1">−6</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">4.9545</td><td align="center" rowspan="1" colspan="1">51</td></tr></tbody></table><table-wrap-foot><p><italic>Notes: MNI, Montreal Neurological Institute; ALFF, amplitude of low-frequency fluctuations; BA, Brodmann area; Hem, hemisphere; HIPP/ParaHIPP, hippocampus/parahippocampus; PCC, posterior cingulate cortex; MFG, middle frontal gyri; false discovery rate (FDR)-corrected, p &lt; 0.05</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">ALFF alterations between the UC and HC groups.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th align="center" colspan="3">MNI peak point coordinates</th><th/><th/></tr><tr><th align="left">Brain region</th><th align="center">BA</th><th align="center">Hem</th><th align="center">X</th><th align="center">Y</th><th align="center">Z</th><th align="center">t-Value</th><th align="center">Voxels</th></tr></thead><tbody><tr><td align="left">HIPP/ParaHIPP</td><td align="center">35</td><td align="center">L&amp;R</td><td align="center">12</td><td align="center">−3</td><td align="center">−30</td><td align="center">−4.9212</td><td align="center">253</td></tr><tr><td align="left">PCC</td><td align="center">31</td><td align="center">L</td><td align="center">−15</td><td align="center">−66</td><td align="center">−12</td><td align="center">4.3442</td><td align="center">58</td></tr><tr><td align="left">MFG</td><td align="center">9/10</td><td align="center">L</td><td align="center">−18</td><td align="center">−6</td><td align="center">57</td><td align="center">4.9545</td><td align="center">51</td></tr></tbody></table></div>Notes: MNI, Montreal Neurological Institute; ALFF, amplitude of low-frequency fluctuations; BA, Brodmann area; Hem, hemisphere; HIPP/ParaHIPP, hippocampus/parahippocampus; PCC, posterior cingulate cortex; MFG, middle frontal gyri; false discovery rate (FDR)-corrected, p &lt; 0.05.</transformed-table></extracted-table><extracted-table><table-id>T3</table-id><table-label>Table 3</table-label><table-caption>FC alterations between the UC and HC groups.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T3" position="float"><label>Table 3</label><caption><p>FC alterations between the UC and HC groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th align="center" colspan="3" rowspan="1">MNI coordinates</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr><tr><th align="center" rowspan="1" colspan="1">Connected regions</th><th align="center" colspan="1" rowspan="1">BA</th><th align="center" rowspan="1" colspan="1">Hem</th><th align="center" colspan="1" rowspan="1">Peak areas</th><th align="center" colspan="1" rowspan="1"><italic>X</italic></th><th align="center" colspan="1" rowspan="1"><italic>Y</italic></th><th align="center" colspan="1" rowspan="1"><italic>Z</italic></th><th align="center" colspan="1" rowspan="1"><italic>t</italic>-Value</th><th align="center" colspan="1" rowspan="1">Voxels</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Seed point (12, −3, −30)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">L&amp;R</td><td align="center" rowspan="1" colspan="1">MFG<sup>a</sup></td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">4.8661</td><td align="center" rowspan="1" colspan="1">209</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">ACC<sup>a</sup></td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">−12</td><td align="center" rowspan="1" colspan="1">4.0674</td><td align="center" rowspan="1" colspan="1">184</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">−</td><td align="center" rowspan="1" colspan="1">L</td><td align="center" rowspan="1" colspan="1">CAU<sup>b</sup></td><td align="center" rowspan="1" colspan="1">−12</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">−6</td><td align="center" rowspan="1" colspan="1">3.938</td><td align="center" rowspan="1" colspan="1">57</td></tr><tr><td align="left" rowspan="1" colspan="1">Seed point (−15, −66, 12)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">L&amp;R</td><td align="center" rowspan="1" colspan="1">MCC<sup>a</sup></td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">−30</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">4.7667</td><td align="center" rowspan="1" colspan="1">562</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">L</td><td align="center" rowspan="1" colspan="1">ANG<sup>a</sup></td><td align="center" rowspan="1" colspan="1">−33</td><td align="center" rowspan="1" colspan="1">−63</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">4.2585</td><td align="center" rowspan="1" colspan="1">153</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">IOG<sup>a</sup></td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">−87</td><td align="center" rowspan="1" colspan="1">−9</td><td align="center" rowspan="1" colspan="1">−4.137</td><td align="center" rowspan="1" colspan="1">74</td></tr><tr><td align="left" rowspan="1" colspan="1">Seed point (−18, −6, 57)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">−</td><td align="center" rowspan="1" colspan="1">−</td><td align="center" rowspan="1" colspan="1">Brainstem<sup>a</sup></td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">−9</td><td align="center" rowspan="1" colspan="1">−18</td><td align="center" rowspan="1" colspan="1">5.7835</td><td align="center" rowspan="1" colspan="1">125</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">IPL<sup>a</sup></td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">−48</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">4.6097</td><td align="center" rowspan="1" colspan="1">110</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">R</td><td align="center" rowspan="1" colspan="1">SFG<sup>a</sup></td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">4.4795</td><td align="center" rowspan="1" colspan="1">99</td></tr></tbody></table><table-wrap-foot><p><italic>Notes: FC, functional connectivity; MFG, middle frontal gyri; ACC, anterior cingulate cortex; CAU, caudate nucleus; MCC, middle cingulate cortex; ANG, angular gyrus; IOG, inferior occipital gyrus; IPL, inferior parietal lobule; SFG, superior frontal gyrus. <sup>a</sup>FDR-corrected <italic>p</italic> &lt; 0.05. <sup>b</sup>Small volume-corrected (FWE-corrected at <italic>p</italic> &lt; 0.05) with a cluster size threshold of 20 contiguous voxels</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">FC alterations between the UC and HC groups.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th/><th align="center" colspan="3">MNI coordinates</th><th/><th/></tr><tr><th align="center">Connected regions</th><th align="center">BA</th><th align="center">Hem</th><th align="center">Peak areas</th><th align="center">X</th><th align="center">Y</th><th align="center">Z</th><th align="center">t-Value</th><th align="center">Voxels</th></tr></thead><tbody><tr><td align="left">Seed point (12, −3, −30)</td><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td/><td align="center">10</td><td align="center">L&amp;R</td><td align="center">MFGa</td><td align="center">18</td><td align="center">54</td><td align="center">6</td><td align="center">4.8661</td><td align="center">209</td></tr><tr><td/><td align="center">24</td><td align="center">R</td><td align="center">ACCa</td><td align="center">21</td><td align="center">30</td><td align="center">−12</td><td align="center">4.0674</td><td align="center">184</td></tr><tr><td/><td align="center">−</td><td align="center">L</td><td align="center">CAUb</td><td align="center">−12</td><td align="center">12</td><td align="center">−6</td><td align="center">3.938</td><td align="center">57</td></tr><tr><td align="left">Seed point (−15, −66, 12)</td><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td/><td align="center">31</td><td align="center">L&amp;R</td><td align="center">MCCa</td><td align="center">0</td><td align="center">−30</td><td align="center">36</td><td align="center">4.7667</td><td align="center">562</td></tr><tr><td/><td align="center">39</td><td align="center">L</td><td align="center">ANGa</td><td align="center">−33</td><td align="center">−63</td><td align="center">30</td><td align="center">4.2585</td><td align="center">153</td></tr><tr><td/><td align="center">19</td><td align="center">R</td><td align="center">IOGa</td><td align="center">30</td><td align="center">−87</td><td align="center">−9</td><td align="center">−4.137</td><td align="center">74</td></tr><tr><td align="left">Seed point (−18, −6, 57)</td><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td/><td align="center">−</td><td align="center">−</td><td align="center">Brainstema</td><td align="center">9</td><td align="center">−9</td><td align="center">−18</td><td align="center">5.7835</td><td align="center">125</td></tr><tr><td/><td align="center">40</td><td align="center">R</td><td align="center">IPLa</td><td align="center">39</td><td align="center">−48</td><td align="center">42</td><td align="center">4.6097</td><td align="center">110</td></tr><tr><td/><td align="center">6</td><td align="center">R</td><td align="center">SFGa</td><td align="center">21</td><td align="center">0</td><td align="center">51</td><td align="center">4.4795</td><td align="center">99</td></tr></tbody></table></div>Notes: FC, functional connectivity; MFG, middle frontal gyri; ACC, anterior cingulate cortex; CAU, caudate nucleus; MCC, middle cingulate cortex; ANG, angular gyrus; IOG, inferior occipital gyrus; IPL, inferior parietal lobule; SFG, superior frontal gyrus. aFDR-corrected p &lt; 0.05. bSmall volume-corrected (FWE-corrected at p &lt; 0.05) with a cluster size threshold of 20 contiguous voxels.</transformed-table></extracted-table></extracted-tables-set>